```json
{
"content": [
{
"type": "paragraph",
"content": "The Chrysanthemum Extract industry trends over the past 18 months reveal a dynamic market shaped by innovation and regulatory shifts. Key developments include strategic partnerships between extract producers and pharmaceutical firms to accelerate R&D for neuroprotective and anti-inflammatory applications. Notably, a major player, ChrysoPharma, collaborated with a leading university to optimize extraction techniques for higher bioavailability. Meanwhile, regulatory updates in the EU and U.S. streamlined approval pathways for chrysanthemum-based nutraceuticals, boosting market confidence. Consumer demand has pivoted toward clean-label functional beverages, with several brands launching chrysanthemum-infused products targeting stress relief and immunity. The sector also witnessed a surge in funding, particularly in Asia-Pacific, where startups secured Series A rounds to expand into Europe and North America. Mergers, such as BioHerbs\' acquisition of a niche extract supplier, underscore consolidation trends. Forward-looking, advancements in sustainable cultivation and precision fermentation are poised to redefine cost structures and scalability."
}
]
}
```
